A mum from Worcester who raised over £1,000 for a Cystic Fibrosis charity has called for the price of a new drug to be lowered so more people can access it.

Yvonne Molloy hosted a fundraising night at Red Hill Social Club in Worcester after her son Oscar was diagnosed with CF at just two weeks old.

Ms Molloy, 35, raised £1,023.77 along with her friend Jackie Wiltshire for the Cystic Fibrosis Trust and is calling for the price of ‘Orkambi’ a new drug to be lowered by the pharmaceutical company that sells it to the NHS.

She said: “We want to start a petition to get it readily available for sufferers and we need to raise awareness of it because CF is such a life-limiting condition.

Efforts to make Orkambi more widely available are backed by more than 200 MPs across the country, including Worcester’s Robin Walker.

Mr Walker said he backed the campaign after several residents raised concerns over the availability of the drug.

He said: “I have had lots of residents get in touch with me concerning the cystic fibrosis drug and I am always happy to take those issues up in parliament on their behalf.”

Orkambi is one of two precision drugs for cystic fibrosis currently licensed for use in the UK by the NHS. It is not currently given to patients except in rare cases or on compassionate grounds.

According to the Cystic Fibrosis Trust website: “Orkambi treats the F508del mutation, which affects around 50 per cent of CF sufferers in the UK.

“The combination of these two things helps to keep a healthy balance of salt and water in the organs particularly the lungs.”

On the official website for Orkambi, side effects are listed such as worsening of liver function, breathing problems, nausea, diarrhoea, headaches and stomach pain.

The National Institute for Health and Care Excellence were unable to recommend Orkambi for general use within the NHS citing cost-effectiveness and a lack of long-term data.